Subcutaneous implantable lead

• US 8,140,171 B2
• Filed: 07/31/2008
• Issued: 03/20/2012
• Est. Priority Date: 07/31/2008
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Havel, William J., Lazeroms, Markus J. C., Rutten, Jean J. G., Smits, Karel F. A. A.
• Primary Examiner(s): Lavert, Nicole F
• Application Number:
  US12/183,568
• Publication Number:
  US 20100030291A1
• Time in Patent Office: 1,328 Days
• Field of Search: 607/5, 607/116, 607/119, 607/122
• US Class Current: 607/116
• CPC Class Codes: A61N 1/0504 Subcutaneous electrodes
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

A subcutaneous implantable device is provided that includes a defibrillation electrode disposed along a portion of a lead, and a lead tip connected to the lead. The lead tip includes a trailing end coupled to a distal end of the lead, and first and second non-parallel sides extending from the trailing end that converge to a leading end that is configured to wedge between tissue layers as the lead is advanced subcutaneously.

Claims

1. A subcutaneous implantable device comprising:

a lead having a proximal end and a distal end;

a defibrillation electrode disposed along a portion of the lead between the proximal end of the lead and the distal end of the lead; and

a lead tip located distally relative to the distal end of the lead, the lead tip comprising;

a trailing end coupled to the distal end of the lead,

a first major surface opposite a second major surface, and

first and second non-parallel sides extending from the trailing end, the first and second non-parallel sides converging to a leading end that is located distally relative to the trailing end and configured to wedge between tissue layers as the lead is advanced subcutaneously, wherein the trailing end, first and second non-parallel sides, and leading end define the peripheries of the first and second major surfaces.

2. The subcutaneous implantable device of claim 1, wherein the trailing end of the lead tip comprises at least one engagement site that is configured to receive a distal end of a subcutaneous implant tool.

3. The subcutaneous implantable device of claim 1, wherein at least a portion of the surface of the lead tip is electrically conductive and configured to sense electrogram signals.

4. The subcutaneous implantable device of claim 3, wherein a portion of the lead tip proximate to the distal end of the lead is covered with an electrically non-conductive material such that only a distal apex portion of the lead tip is electrically conductive.

5. The subcutaneous implantable device of claim 1, wherein the first and second non-parallel sides of the lead tip extend between opposing parallel major surfaces of the lead tip.

6. The subcutaneous implantable device of claim 1, wherein the lead tip comprises a substantially triangular periphery defined by the first and second non-parallel sides and the trailing end.

7. The subcutaneous implantable device of claim 1, wherein the leading end of the lead tip comprises an apex of the substantially triangular periphery, the apex having a surface area that is less than a surface area of the trailing end.

8. The subcutaneous implantable device of claim 1, further comprising:

at least one satellite electrode coupled to the trailing end of the lead tip, the at least one satellite electrode electrically coupled with the defibrillation electrode at the lead tip.

9. The subcutaneous implantable device of claim 1, further comprising:

a leading electrode disposed on a leading end of the lead tip, the leading electrode electrically isolated from the defibrillation electrode and configured to sense electrogram signals.

10. The subcutaneous implantable device of claim 1, further comprising:

an implantable cardiodefibrillator (ICD) coupled to the proximal end of the lead.

11. A subcutaneous implantable lead system comprising:

a lead having a proximal end and a distal end, the lead comprising a defibrillation electrode disposed between the proximal end of the lead and the distal end of the lead;

a lead tip located distally relative to the distal end of the lead and coupled to the distal end of the lead, the lead tip comprising opposed major surfaces each having a substantially triangular periphery defined by a trailing side and first and second non-parallel sides extending from the trailing side that converge to a leading apex of the lead tip, wherein the trailing side is coupled to a distal end of the defibrillation electrode and comprises a tool engagement site, and wherein the leading apex is located distally relative to the trailing side; and

a tunneling tool configured to removably couple with the tool engagement site and subcutaneously advance the lead tip and the lead.

12. The lead system of claim 11, wherein the tool engagement site comprises a recess formed in the trailing side of the lead tip, and a distal end of the tunneling tool is insertable into the recess for subcutaneously advancing the lead tip and removable from the recess for removal of the tunneling tool.

13. The lead system of claim 11, wherein the tunneling tool comprises a lead tensioning device that is configured to maintain tension on the lead between the lead tip and a proximal end portion of the tunneling tool.

14. The lead system of claim 11, wherein the lead tensioning device comprises a lead clamp coupled to a proximal end portion of the tunneling tool.